US Patent Issued to Syntex on July 22 for "Recombinant chorionic gonadotropin, procedure for preparation, pharmaceutical compositions and uses of the same" (Argentinean Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,715, issued on July 22, was assigned to Syntex S.A. (Buenos Aires, Argentina).

"Recombinant chorionic gonadotropin, procedure for preparation, pharmaceutical compositions and uses of the same" was invented by Juan Manuel Perez Saez (Ciudad Autonoma de Buenos Aires, Argentina) and Leonardo Edmundo Bussmann (Florida, Argentina).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to a recombinant single chain chorionic gonadotropin polypeptide, having an amino acid sequence encoding the beta chain and the alpha chain of the equine chorionic gonadotropin linked to one or more sequences that include glycosylation sites, which results in ...